Development and Characterization of Hyaluronic Acid Microgels for Neural Regeneration Applications

Area of Science:

• Biomaterials science
• Neuroscience
• Regenerative medicine

Background:

• Biomaterial systems offer promise for tissue regeneration after central nervous system (CNS) injuries.
• Stromal cell-derived factor-1a (SDF-1a) is crucial for progenitor cell recruitment to neural injury sites but has a short half-life, necessitating a delivery system.
• Controlled release of therapeutic factors is essential for effective neural repair.

Purpose of the Study:

• To develop a microgel-based drug delivery platform for controlled release of SDF-1a.
• To minimize inflammation associated with therapeutic delivery systems.
• To assess the efficacy of SDF-1a-loaded microgels in a mouse model of traumatic brain injury.

Main Methods:

• Modified hyaluronic acid and microfluidics were used to create monodisperse microgels.
• Microgels were characterized for size, tunability, degradation, and controlled release properties.
• SDF-1a-loaded microgels were delivered to mice with traumatic brain injury, and neural progenitor cell recruitment and astrogliosis were assessed.

Main Results:

• The microfluidic system successfully produced highly monodisperse microgels.
• Microgels effectively encapsulated a matrix metalloproteinase (MMP)-cleavable SDF-1a peptide and were sensitive to collagenase.
• Intracortical injections of microgels did not increase astrogliosis compared to saline controls, and neural progenitor cell migration showed no significant difference.

Conclusions:

• A biocompatible microgel system was developed for adaptable biological delivery.
• This system can be utilized in brain and neural applications without exacerbating neuroinflammation.
• The microgel platform shows potential for controlled delivery of therapeutic agents in CNS injury contexts.